AU2001285257A1 - Human telomerase rna elements - Google Patents

Human telomerase rna elements

Info

Publication number
AU2001285257A1
AU2001285257A1 AU2001285257A AU8525701A AU2001285257A1 AU 2001285257 A1 AU2001285257 A1 AU 2001285257A1 AU 2001285257 A AU2001285257 A AU 2001285257A AU 8525701 A AU8525701 A AU 8525701A AU 2001285257 A1 AU2001285257 A1 AU 2001285257A1
Authority
AU
Australia
Prior art keywords
human telomerase
telomerase rna
rna elements
elements
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285257A
Inventor
Kathleen Collins
James R. Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2001285257A1 publication Critical patent/AU2001285257A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/20Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001285257A 2000-08-24 2001-08-24 Human telomerase rna elements Abandoned AU2001285257A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09645713 2000-08-24
US09/645,713 US6342358B1 (en) 2000-08-24 2000-08-24 Human telomerase RNA elements
PCT/US2001/026468 WO2002016386A1 (en) 2000-08-24 2001-08-24 Human telomerase rna elements

Publications (1)

Publication Number Publication Date
AU2001285257A1 true AU2001285257A1 (en) 2002-03-04

Family

ID=24590143

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285257A Abandoned AU2001285257A1 (en) 2000-08-24 2001-08-24 Human telomerase rna elements

Country Status (4)

Country Link
US (1) US6342358B1 (en)
AU (1) AU2001285257A1 (en)
GB (1) GB0305841D0 (en)
WO (1) WO2002016386A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1210357T3 (en) * 1999-09-10 2008-07-21 Geron Corp Oligonucleotide N3 '-P5' Thiophosphoramidates: Synthesis and Use thereof
US8377992B2 (en) 2007-10-22 2013-02-19 The Wistar Institute TRBD-binding effectors and methods for using the same to modulate telomerase activity
EP2205759A4 (en) 2007-10-22 2013-04-24 Wistar Inst Method for identifying a compound that modulates telomerase activity
AU2009302385B2 (en) * 2008-10-07 2015-12-03 President And Fellows Of Harvard College Telomerase inhibitors and methods of use thereof
US9885711B2 (en) 2009-09-25 2018-02-06 Xoma Technology Ltd. Screening methods
US8926976B2 (en) * 2009-09-25 2015-01-06 Xoma Technology Ltd. Modulators
EP4015040A1 (en) * 2020-12-16 2022-06-22 Fundación para la Formación e Investigación Sanitarias de la Región de Murcia Method for treating blood diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776679A (en) * 1994-07-07 1998-07-07 Geron Corporation Assays for the DNA component of human telomerase
US6015710A (en) * 1996-04-09 2000-01-18 The University Of Texas System Modulation of mammalian telomerase by peptide nucleic acids
US5747317A (en) * 1996-07-08 1998-05-05 Tularik Inc. Human telomerase RNA interacting protein gene

Also Published As

Publication number Publication date
US6342358B1 (en) 2002-01-29
WO2002016386A1 (en) 2002-02-28
GB0305841D0 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AU2001243462A1 (en) Improved thoraco-lumbo-sacral orthosis
AU9517301A (en) Implant
AU2001263841A1 (en) Implant
AU2001262691A1 (en) Cosmetic preparation
AU2001233208A1 (en) Human sulfatases
AU2001268525A1 (en) Human kinases
AU2002224553A1 (en) Human proteases
AU2001238488A1 (en) Human kinases
AU2001288612A1 (en) Human kinases
AU2001277959A1 (en) Human kinases
AU2001242625A1 (en) Gene sequence
AU2001240791A1 (en) Sequence
AU2002227925A1 (en) Human beta-defensin-3
AU2001270129A1 (en) Human phosphodiesterases
AU2001285257A1 (en) Human telomerase rna elements
AU2001264247A1 (en) GASC1 gene
AU2001295841A1 (en) Human dna sequences
AU2001235899A1 (en) Implantation
AU2001255573A1 (en) Human kinases
AU2002227352A1 (en) Human kinases
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001228624A1 (en) Implements and their manufacture
AU2001285743A1 (en) Adipose-related gene
AU2001254736A1 (en) Encymatical colorant
AU2001271244A1 (en) Novel human uridine kinase